Myasthenia gravis improvement in a patient receiving sunitinib for metastatic renal cell carcinoma

Neurology; Oncology; Urology
Case Report
10.1102/1470-5206.2010.0008
10
42-45
Myasthenia gravis improvement in a patient receiving sunitinib for metastatic renal cell carcinoma

We present a case of a 59-year-old gentleman with myasthenia gravis and metastatic renal cell carcinoma that resolved on sunitinib. The clear temporal relationship between the patient receiving sunitinib for renal cell carcinoma and the resolution of his myasthenia gravis suggests that the improvement was due either to a paraneoplastic condition responding to treatment of the underlying malignancy or to a direct effect of sunitinib.

application/pdf iconView article
885.63 KB

Editor-in-Chief

Frank Cross
Consultant Vascular and General Surgeon
The London Clinic, UK

Editors

Neil Barnes
Consultant Physician
Barts Health NHS Trust, London, UK
Ali Jawad
Professor of Rheumatology
Barts Health NHS Trust, London, UK

Join our newsletter

* indicates required

view counter
view counter
view counter
view counter
view counter